Age-distinct predictors of symptomatic cervicocephalic atherosclerosis

Cerebrovascular Diseases

Volumn 27, Issue 1, 2009, Pages 13-21

  Bang, Oh Young ^a,c   Saver, Jeffrey L ^c   Liebeskind, David S ^c   Lee, Phil Hyu ^b   Sheen, Seung Soo ^b   Yoon, Sa Rah ^c   Yun, Susan W ^c   Kim, Gyeong Moon ^a   Chung, Chin Sang ^a   Lee, Kwang Ho ^a   Ovbiagele, Bruce ^c  

^a Sungkyunkwan University   (South Korea)

^b Ajou University   (South Korea)

^c UCLA MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Ischemic stroke; Stenosis; Stroke; Vascular risk factors

Indexed keywords

ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CIGARETTE SMOKING; EVALUATION; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; ONSET AGE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE; SOUTH KOREA; STROKE; STROKE PATIENT; SYMPTOM; UNITED STATES;

AGE FACTORS; AGED; ATHEROSCLEROSIS; CALIFORNIA; CEREBRAL ARTERIES; ETHNIC GROUPS; FEMALE; HUMANS; KOREA; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; STROKE;

EID: 56149113308     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000172629     Document Type: Article

References (31)

1. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC Jr, Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P: Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113:e85-e151.
2. Warlow C, Dennis MS, Van Gijn J, Hankey GJ, Sandercock PA, Bamford J, Wardlaw J: What caused this ischaemic event?; in Stroke: a Practical Guide to Management. Oxford, Blackwell Science, 2001, pp 223-300.
3. Hankey GJ: Long-term outcome after ischaemic stroke/transient ischaemic attack. Cerebrovasc Dis 2003;16(suppl 1):14-19.
4. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T: Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006;37:577-617.
5. Gorelick PB: Stroke prevention therapy beyond antithrombotics: unifying mechanisms in ischemic stroke pathogenesis and implications for therapy: an invited review. Stroke 2002;33:862-875.
6. Bang OY, Lee PH, Joo SY, Lee JS, Joo IS, Huh K: Frequency and mechanisms of stroke recurrence after cryptogenic stroke. Ann Neurol 2003;54:227-234.
7. Smaha LA: The American Heart Association Get With The Guidelines program. Am Heart J 2004;148:S46-S48.
8. Lee LJ, Kidwell CS, Alger J, Starkman S, Saver JL: Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography. Stroke 2000;31:1081-1089.
9. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421.
10. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-553.
11. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991;325:445-453.
12. Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI: A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 2000;21:643-646.
13. White H, Boden-Albala B, Wang C, Elkind MS, Rundek T, Wright CB, Sacco RL: Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation 2005;111:1327-1331.
14. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, Degraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL: Primary prevention of ischemic stroke: a guideline from the American Heart Association/ American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke 2006;37:1583-1633.
15. Lee TH, Hsu WC, Chen CJ, Chen ST: Etiologic study of young ischemic stroke in Taiwan. Stroke 2002;33:1950-1955.
16. Johnson HM, Douglas PS, Srinivasan SR, Bond MG, Tang R, Li S, Chen W, Berenson GS, Stein JH: Predictors of carotid intimamedia thickness progression in young adults: the Bogalusa Heart Study. Stroke 2007;38:900-905.
17. Li W, Ma D, Liu M, Liu H, Feng S, Hao Z, Wu B, Zhang S: Association between metabolic syndrome and risk of stroke: a meta-analysis of cohort studies. Cerebrovasc Dis 2008;25:539-547.
18. van den Berg E, Biessels GJ, de Craen AJ, Gussekloo J, Westendorp RG: The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology 2007;69:979-985.
19. Schulz UG, Rothwell PM: Differences in vascular risk factors between etiological subtypes of ischemic stroke: importance of population-based studies. Stroke 2003;34:2050-2059.
20. Ohira T, Shahar E, Chambless LE, Rosamond WD, Mosley TH Jr, Folsom AR: Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities study. Stroke 2006;37:2493-2498.
21. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO: Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke 1999;30:2513-2516.
22. Schneider AT, Kissela B, Woo D, Kleindorfer D, Alwell K, Miller R, Szaflarski J, Gebel J, Khoury J, Shukla R, Moomaw C, Pancioli A, Jauch E, Broderick J: Ischemic stroke subtypes: a population-based study of incidence rates among blacks and whites. Stroke 2004;35:1552-1556.
23. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU: Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke 2001;32:2735-2740.
24. Woo D, Gebel J, Miller R, Kothari R, Brott T, Khoury J, Salisbury S, Shukla R, Pancioli A, Jauch E, Broderick J: Incidence rates of first-ever ischemic stroke subtypes among blacks: a population-based study. Stroke 1999;30:2517-2522.
25. Tanizaki Y, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Shinohara N, Arima H, Tanaka K, Ibayashi S, Fujishima M: Incidence and risk factors for subtypes of cerebral infarction in a general population: the Hisayama study. Stroke 2000;31:2616-2622.
26. Lavados PM, Sacks C, Prina L, Escobar A, Tossi C, Araya F, Feuerhake W, Galvez M, Salinas R, Alvarez G: Incidence, case-fatality rate, and prognosis of ischaemic stroke subtypes in a predominantly Hispanic-Mestizo population in Iquique, Chile (PISCIS project): a community-based incidence study. Lancet Neurol 2007;6:140-148.
27. Sacco RL, Kargman DE, Gu Q, Zamanillo MC: Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 1995;26:14-20.
28. Sacco RL, Boden-Albala B, Abel G, Lin IF, Elkind M, Hauser WA, Paik MC, Shea S: Race-ethnic disparities in the impact of stroke risk factors: the northern Manhattan stroke study. Stroke 2001;32:1725-1731.
29. Whisnant JP, Wiebers DO, O'Fallon WM, Sicks JD, Frye RL: A population-based model of risk factors for ischemic stroke: Rochester, Minnesota. Neurology 1996;47:1420-1428.
30. Arboix A, Morcillo C, Garcia-Eroles L, Oliveres M, Massons J, Targa C: Different vascular risk factor profiles in ischemic stroke subtypes: a study from the 'Sagrat Cor Hospital of Barcelona Stroke Registry'. Acta Neurol Scand 2000;102:264-270.
31. Curb JD, Abbott RD, Rodriguez BL, Sakkinen P, Popper JS, Yano K, Tracy RP: C-reactive protein and the future risk of thromboembolic stroke in healthy men. Circulation 2003;107:2016-2020.